Citadel Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $83.7M | Sell |
600,300
-438,900
| -42% | -$61.5M | 0.01% | 937 |
|
|
2025
Q4 | $128M | Sell |
1,039,200
-191,300
| -16% | -$23.2M | 0.02% | 712 |
|
|
2025
Q3 | $137M | Sell |
1,230,500
-392,600
| -24% | -$44.6M | 0.02% | 663 |
|
|
2025
Q2 | $180M | Buy |
1,623,100
+587,700
| +57% | +$62.5M | 0.03% | 451 |
|
|
2025
Q1 | $116M | Sell |
1,035,400
-351,800
| -25% | -$36.3M | 0.02% | 606 |
|
|
2024
Q4 | $128M | Buy |
1,387,200
+192,300
| +16% | +$17.3M | 0.02% | 604 |
|
|
2024
Q3 | $100M | Sell |
1,194,900
-348,800
| -23% | -$26.6M | 0.02% | 697 |
|
|
2024
Q2 | $106M | Sell |
1,543,700
-53,400
| -3% | -$3.56M | 0.02% | 654 |
|
|
2024
Q1 | $117M | Buy |
1,597,100
+379,700
| +31% | +$29.2M | 0.02% | 611 |
|
|
2023
Q4 | $98.6M | Sell |
1,217,400
-100,600
| -8% | -$7.83M | 0.02% | 687 |
|
|
2023
Q3 | $98.8M | Buy |
1,318,000
+278,400
| +27% | +$21.4M | 0.02% | 633 |
|
|
2023
Q2 | $80.1M | Sell |
1,039,600
-60,000
| -5% | -$4.79M | 0.02% | 753 |
|
|
2023
Q1 | $91.2M | Sell |
1,099,600
-551,900
| -33% | -$45.7M | 0.02% | 671 |
|
|
2022
Q4 | $142M | Sell |
1,651,500
-224,600
| -12% | -$17.8M | 0.03% | 485 |
|
|
2022
Q3 | $116M | Sell |
1,876,100
-237,700
| -11% | -$15M | 0.03% | 531 |
|
|
2022
Q2 | $131M | Sell |
2,113,800
-1,223,300
| -37% | -$75.7M | 0.03% | 437 |
|
|
2022
Q1 | $198M | Buy |
3,337,100
+571,900
| +21% | +$36.6M | 0.04% | 343 |
|
|
2021
Q4 | $201M | Sell |
2,765,200
-458,100
| -14% | -$31.6M | 0.04% | 345 |
|
|
2021
Q3 | $225M | Sell |
3,223,300
-829,900
| -20% | -$58.3M | 0.05% | 306 |
|
|
2021
Q2 | $279M | Sell |
4,053,200
-728,300
| -15% | -$48.6M | 0.06% | 223 |
|
|
2021
Q1 | $309M | Sell |
4,781,500
-328,500
| -6% | -$21.2M | 0.08% | 170 |
|
|
2020
Q4 | $298M | Sell |
5,110,000
-334,300
| -6% | -$20.2M | 0.08% | 161 |
|
|
2020
Q3 | $344M | Buy |
5,444,300
+158,200
| +3% | +$11M | 0.1% | 102 |
|
|
2020
Q2 | $407M | Buy |
5,286,100
+1,755,000
| +50% | +$134M | 0.15% | 61 |
|
|
2020
Q1 | $264M | Buy |
3,531,100
+42,100
| +1% | +$2.91M | 0.12% | 90 |
|
|
2019
Q4 | $227M | Buy |
3,489,000
+920,600
| +36% | +$60M | 0.1% | 147 |
|
|
2019
Q3 | $163M | Buy |
2,568,400
+461,700
| +22% | +$30.2M | 0.08% | 212 |
|
|
2019
Q2 | $142M | Sell |
2,106,700
-455,600
| -18% | -$30M | 0.07% | 262 |
|
|
2019
Q1 | $167M | Buy |
2,562,300
+640,400
| +33% | +$42.6M | 0.08% | 190 |
|
|
2018
Q4 | $120M | Buy |
1,921,900
+51,800
| +3% | +$3.62M | 0.07% | 268 |
|
|
2018
Q3 | $144M | Sell |
1,870,100
-234,400
| -11% | -$17.7M | 0.06% | 280 |
|
|
2018
Q2 | $149M | Buy |
2,104,500
+433,200
| +26% | +$30.6M | 0.07% | 238 |
|
|
2018
Q1 | $126M | Sell |
1,671,300
-1,169,900
| -41% | -$93M | 0.07% | 237 |
|
|
2017
Q4 | $204M | Buy |
2,841,200
+1,251,200
| +79% | +$95M | 0.12% | 135 |
|
|
2017
Q3 | $129M | Buy |
1,590,000
+143,800
| +10% | +$11M | 0.1% | 174 |
|
|
2017
Q2 | $102M | Buy |
1,446,200
+284,000
| +24% | +$18.9M | 0.09% | 219 |
|
|
2017
Q1 | $78.9M | Sell |
1,162,200
-88,900
| -7% | -$6.25M | 0.07% | 261 |
|
|
2016
Q4 | $89.6M | Sell |
1,251,100
-79,700
| -6% | -$5.92M | 0.09% | 197 |
|
|
2016
Q3 | $105M | Buy |
1,330,800
+428,200
| +47% | +$34.8M | 0.11% | 155 |
|
|
2016
Q2 | $75.3M | Buy |
902,600
+117,100
| +15% | +$10.4M | 0.08% | 208 |
|
|
2016
Q1 | $72.2M | Buy |
785,500
+142,100
| +22% | +$12.8M | 0.09% | 194 |
|
|
2015
Q4 | $65.1M | Sell |
643,400
-390,000
| -38% | -$40.6M | 0.07% | 296 |
|
|
2015
Q3 | $101M | Buy |
1,033,400
+85,700
| +9% | +$9.52M | 0.1% | 198 |
|
|
2015
Q2 | $111M | Buy |
947,700
+295,800
| +45% | +$32.3M | 0.1% | 212 |
|
|
2015
Q1 | $64M | Sell |
651,900
-458,400
| -41% | -$46.5M | 0.06% | 373 |
|
|
2014
Q4 | $105M | Buy |
1,110,300
+423,000
| +62% | +$43.7M | 0.1% | 190 |
|
|
2014
Q3 | $73.2M | Sell |
687,300
-43,400
| -6% | -$4.25M | 0.08% | 266 |
|
|
2014
Q2 | $60.6M | Sell |
730,700
-420,300
| -37% | -$32.7M | 0.07% | 299 |
|
|
2014
Q1 | $81.6M | Buy |
1,151,000
+363,400
| +46% | +$28.5M | 0.1% | 216 |
|
|
2013
Q4 | $59.2M | Buy |
787,600
+118,400
| +18% | +$8.24M | 0.08% | 293 |
|
|
2013
Q3 | $42.1M | Sell |
669,200
-20,200
| -3% | -$1.21M | 0.06% | 380 |
|
|
2013
Q2 | $35.3M | Buy |
+689,400
| New | +$35.9M | 0.06% | 373 |
|
Other funds holding GILD
VCM
VPM
Citadel Advisors's GILD Position: Q1 2026 in Review
Citadel Advisors increased its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, buying an estimated $13.3M and bringing the position to 3,982,185 shares worth $555M. The position accounts for 0.09% of the portfolio, ranked #156.
Citadel Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $607M in Q2 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Citadel Advisors held 3,982,185 shares of Gilead Sciences worth $555M as of Q1 2026.
- Citadel Advisors bought 94,665 Gilead Sciences shares in Q1 2026, an estimated $13.3M.
- Gilead Sciences made up 0.09% of Citadel Advisors's portfolio in Q1 2026, its #156 holding.
- Citadel Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Gilead Sciences position peaked at $607M in Q2 2025.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.